The bone: stromal cell interface in arthritis
The link between stromal cells that control inflammation and tissue damage remains unclear. To this end we have endeavoured to identify stromal cell markers that are upregulated in rheumatoid arthritis and then assess their function. This seminar will discuss one such marker, CD248/Endosialin, and our finding that it acts as a negative regulator of bone formation under resting conditions. We have recently identified a novel, endothelial-specific complex (Multimerin-CLEC14A) for CD248 and demonstrated that this complex is required for sprouting angiogenesis. Given that the vasculature plays a crucial role in controlling osteoblast trafficking and maturation we are now exploring the implications of manipulating this pathway during synovial inflammation and bone damage.
Date:
10 September 2018, 12:00 (Monday, 21st week, Trinity 2018)
Venue:
Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details:
Bernard Sunley Lecture Theatre
Speaker:
Dr Amy Naylor (University of Birmingham)
Organising department:
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Organisers:
Laura Sánchez Lazo (Kennedy Institute of Rheumatology),
Professor Irina Udalova (Kennedy Institute of Rheumatology),
Jo Silva (NDORMS),
Wulf Forrester-Barker (University of Oxford, Nuffield Dept of Orthopaedics Rheumatology and Musculoskeletal Sciences)
Host:
Professor Christopher Buckley (University of Birmingham)
Part of:
Kennedy Institute Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Laura Sanchez Lazo
